Literature DB >> 12857972

T cell signaling and apoptosis in HIV disease.

Nithianandan Selliah1, Jason Shackelford, Jiang-Fang Wang, Frank Traynor, Jiyi Yin, Terri H Finkel.   

Abstract

Groundbreaking research has led to an understanding of some of the pathogenic mechanisms of HIV-1 infection. Surprisingly, an unanswered question remains the mechanism(s) by which HIV-1 inactivates or kills T cells. Our goals are to define candidate T cell signaling cascades altered by HIV infection and to identify mechanisms whereby HIV-infected cells escape the apoptosis triggered by this aberrant signaling. In earlier work, we found that HIV reprograms healthy T cells to self-destruct by a process called apoptosis. We asked whether apoptosis occurs in organs of infected people and made a surprising discovery-this cell death occurs predominantly in healthy bystander cells and only rarely in infected cells. We hypothesize that HIV may be doubly diabolical-healthy T cells are killed in HIV infection, while infected cells resist killing. Thus, the virus protects its viral factory and allows HIV to turn the cell into a "Trojan Horse," with the virus in hiding or "latent." In this review, we discuss the role of viral and cellular proteins in HIV induced T cell anergy and death. We also discuss mechanisms by which HIV may protect infected T cells from apoptosis. These studies will yield new insights into the pathogenesis of AIDS, identify cellular targets that regulate HIV-1 infection, and suggest novel therapeutic approaches to cure HIV infection.

Entities:  

Mesh:

Year:  2003        PMID: 12857972     DOI: 10.1385/IR:27:2-3:247

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  66 in total

1.  Apoptosis subversion: HIV-Nef provides both armor and sword.

Authors:  J C Ameisen
Journal:  Nat Med       Date:  2001-11       Impact factor: 53.440

2.  New developments in the biology and treatment of HIV.

Authors:  F Bushman; N R Landau; E A Emini
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-15       Impact factor: 11.205

3.  Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy.

Authors:  T W Chun; L Stuyver; S B Mizell; L A Ehler; J A Mican; M Baseler; A L Lloyd; M A Nowak; A S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-25       Impact factor: 11.205

4.  Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity.

Authors:  J He; S Choe; R Walker; P Di Marzio; D O Morgan; N R Landau
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

5.  Apoptosis of CD4+ and CD8+ T cells isolated immediately ex vivo correlates with disease severity in human immunodeficiency virus type 1 infection.

Authors:  M F Cotton; D N Ikle; E L Rapaport; S Marschner; P O Tseng; R Kurrle; T H Finkel
Journal:  Pediatr Res       Date:  1997-11       Impact factor: 3.756

6.  Overexpression of Fas antigen on T cells in advanced HIV-1 infection: differential ligation constantly induces apoptosis.

Authors:  F Silvestris; P Cafforio; M A Frassanito; M Tucci; A Romito; S Nagata; F Dammacco
Journal:  AIDS       Date:  1996-02       Impact factor: 4.177

7.  T cells from Jak3-deficient mice have intact TCR signaling, but increased apoptosis.

Authors:  D C Thomis; W Lee; L J Berg
Journal:  J Immunol       Date:  1997-11-15       Impact factor: 5.422

8.  Presence of CD3+CD8+Bcl-2(low) lymphocytes undergoing apoptosis and activated macrophages in lymph nodes of HIV-1+ patients.

Authors:  M Bofill; W Gombert; N J Borthwick; A N Akbar; J E McLaughlin; C A Lee; M A Johnson; A J Pinching; G Janossy
Journal:  Am J Pathol       Date:  1995-06       Impact factor: 4.307

9.  Programmed cell death in peripheral lymphocytes from HIV-infected persons: increased susceptibility to apoptosis of CD4 and CD8 T cells correlates with lymphocyte activation and with disease progression.

Authors:  M L Gougeon; H Lecoeur; A Dulioust; M G Enouf; M Crouvoiser; C Goujard; T Debord; L Montagnier
Journal:  J Immunol       Date:  1996-05-01       Impact factor: 5.422

10.  Impaired primary T cell responses in L-selectin-deficient mice.

Authors:  J Xu; I S Grewal; G P Geba; R A Flavell
Journal:  J Exp Med       Date:  1996-02-01       Impact factor: 14.307

View more
  6 in total

1.  Molecular interactions of human immunodeficiency virus type 1 with primary human oral keratinocytes.

Authors:  Edward A Acheampong; Zahida Parveen; Lois W Muthoga; Vivian Wasmuth-Peroud; Mehrnush Kalayeh; Adnan Bashir; Robert Diecidue; Muhammad Mukhtar; Roger J Pomerantz
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

Review 2.  Evidence for the innate immune response as a correlate of protection in human immunodeficiency virus (HIV)-1 highly exposed seronegative subjects (HESN).

Authors:  C Tomescu; S Abdulhaqq; L J Montaner
Journal:  Clin Exp Immunol       Date:  2011-03-17       Impact factor: 4.330

3.  Bystander macrophage apoptosis after Mycobacterium tuberculosis H37Ra infection.

Authors:  Deirdre M Kelly; Annemieke M C ten Bokum; Seonadh M O'Leary; Mary P O'Sullivan; Joseph Keane
Journal:  Infect Immun       Date:  2007-10-22       Impact factor: 3.441

4.  Inhibition of HIV-1 replication by small interfering RNAs directed against glioma pathogenesis related protein (GliPR) expression.

Authors:  Gianni Capalbo; Thea Müller-Kuller; Ursula Dietrich; Dieter Hoelzer; Oliver G Ottmann; Urban J Scheuring
Journal:  Retrovirology       Date:  2010-03-31       Impact factor: 4.602

5.  Late expression of granulysin by microbicidal CD4+ T cells requires PI3K- and STAT5-dependent expression of IL-2Rbeta that is defective in HIV-infected patients.

Authors:  Chun Fu Zheng; Gareth J Jones; Meiqing Shi; Jeremy C D Wiseman; Kaleb J Marr; Byron M Berenger; Shaunna M Huston; M John Gill; Alan M Krensky; Paul Kubes; Christopher H Mody
Journal:  J Immunol       Date:  2008-06-01       Impact factor: 5.422

6.  TRBP-Dicer interaction may enhance HIV-1 TAR RNA translation via TAR RNA processing, repressing host-cell apoptosis.

Authors:  Chiaki Komori; Tomoko Takahashi; Yuko Nakano; Kumiko Ui-Tei
Journal:  Biol Open       Date:  2020-02-25       Impact factor: 2.422

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.